Jerash | 10-Q: FY2026 Q2 Revenue Beats Estimate at USD 41.97 M

LB filings
2025.11.12 21:19
portai
I'm PortAI, I can summarize articles.

Revenue: As of FY2026 Q2, the actual value is USD 41.97 M, beating the estimate of USD 41 M.

EPS: As of FY2026 Q2, the actual value is USD 0.04.

EBIT: As of FY2026 Q2, the actual value is USD 1.583 M.

Revenue

  • Three Months Ended September 30, 2025: $41,968,534
  • Three Months Ended September 30, 2024: $40,240,127
  • Six Months Ended September 30, 2025: $81,597,842
  • Six Months Ended September 30, 2024: $81,175,843

Gross Profit

  • Three Months Ended September 30, 2025: $6,289,680
  • Three Months Ended September 30, 2024: $7,057,883
  • Six Months Ended September 30, 2025: $12,378,560
  • Six Months Ended September 30, 2024: $11,697,754

Operating Expenses

  • Three Months Ended September 30, 2025: $5,200,292
  • Three Months Ended September 30, 2024: $5,923,474
  • Six Months Ended September 30, 2025: $10,330,176
  • Six Months Ended September 30, 2024: $11,392,153

Net Income

  • Three Months Ended September 30, 2025: $479,303
  • Three Months Ended September 30, 2024: $664,549
  • Six Months Ended September 30, 2025: $802,933
  • Six Months Ended September 30, 2024: -$702,148

Cash Flow

  • Net Cash Provided by Operating Activities: $318,278 for the six months ended September 30, 2025, compared to $2,426,620 for the same period in fiscal 2025.
  • Net Cash Used in Investing Activities: -$1,053,944 for the six months ended September 30, 2025, compared to -$936,223 for the same period in fiscal 2025.
  • Net Cash (Used in) Provided by Financing Activities: -$606,018 for the six months ended September 30, 2025, compared to $2,340,753 for the same period in fiscal 2025.

Future Outlook and Strategy

  • Core Business Focus: The company plans to continue its efforts in diversifying its customer base and controlling costs to improve margins. The company projects capital expenditures of approximately $7.8 million, $14.5 million, $16.5 million, $3.5 million, and $2 million in each of the five fiscal years from the fiscal year ending March 31, 2026, to the fiscal year ending March 31, 2030, for further enhancement of production capacity to meet future sales growth.
  • Non-Core Business: The company is also exploring opportunities in new markets and product lines, including personal protective equipment.